Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retina Pathology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00511706
What this trial is testing

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 243
Not applicableLooking for participantsNCT07151001
What this trial is testing

Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy

Who this might be right for
DiabetesDiabetic Retinopathy
iHealthScreen Inc 922
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Not applicableLooking for participantsNCT07085533
What this trial is testing

Natural History Study of Inherited Retinal Diseases

Who this might be right for
Retinal DystrophiesColor Vision DefectsVision Disorders+7 more
Zhongmou Therapeutics 200
Testing effectiveness (Phase 2)Looking for participantsNCT06591793
What this trial is testing

Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa

Who this might be right for
Usher Syndrome, Type 1B
AAVantgarde Bio Srl 15
Not applicableStudy completedNCT00991666
What this trial is testing

Association Between Laser Interferometric Measurement of Fundus Pulsation and Pneumotonometric Measurement of Pulsatile Ocular Blood Flow in Patients With Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Medical University of Vienna 100
Early research (Phase 1)UnknownNCT02050971
What this trial is testing

Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates

Who this might be right for
Anemia, NeonatalIntracranial HemorrhagesNecrotizing Enterocolitis+3 more
Pomeranian Medical University Szczecin 40
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Not applicableStudy completedNCT05324150
What this trial is testing

M Charts Versus Amsler Test in Evaluating Metamorphopsia in nAMD

Who this might be right for
Macular Degeneration, WetMetamorphopsia
Ospedale Santa Croce-Carle Cuneo 57
Not applicableStudy completedNCT04906135
What this trial is testing

Auditory Neural Function in Implanted Patients With Usher Syndrome

Who this might be right for
Usher SyndromeCochlear Implantation
Ohio State University 29
Not applicableStudy completedNCT04125043
What this trial is testing

Accuracy of the Red Reflex Test in the Pediatric Population

Who this might be right for
Abnormal Vitreous Humor MorphologyAbnormal Choroid MorphologyOptic Nerve Diseases+2 more
Children's National Research Institute 84
Not applicableUnknownNCT04352790
What this trial is testing

Multifactorial Risk Stratification in Stroke Patients With Cardiac Disease

Who this might be right for
StrokeCardiac Disease
University Hospital Tuebingen 878
Testing effectiveness (Phase 2)Study completedNCT00344227
What this trial is testing

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

Who this might be right for
Neovascular Age-Related Macular Degeneration
University of Miami 40
Not applicableUnknownNCT05447845
What this trial is testing

Rapid Computerized Visual Acuity Test

Who this might be right for
Vision DisordersRefractive ErrorsRetinal Disease+2 more
Rambam Health Care Campus 200
Large-scale testing (Phase 3)Study completedNCT06270836
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)

Who this might be right for
Diabetic Retinopathy
Kodiak Sciences Inc 255
Not applicableStudy completedNCT06888765
What this trial is testing

Effects of Differences in Body Composition on Retina and Choroid

Who this might be right for
ObesityObesity, MorbidBody Composition
Bayram Meydan 261
Testing effectiveness (Phase 2)Study completedNCT01414153
What this trial is testing

Efficacy and Safety Study of iSONEP With & Without Lucentis/Avastin/Eylea to Treat Wet AMD

Who this might be right for
Exudative Age-related Macular Degeneration
Lpath, Inc. 158
Not applicableTemporarily pausedNCT05956067
What this trial is testing

Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity

Who this might be right for
Chronic Low-back PainChronic PainFibromyalgia
University of North Carolina, Chapel Hill 60
Not applicableNot Yet RecruitingNCT07427719
What this trial is testing

Retinopathy of Prematurity - Visual Function and Retinal Structure

Who this might be right for
Retinopathy of Prematurity (ROP)Prematurity ComplicationsCerebral Visual Impairment+1 more
Oslo University Hospital 140
Testing effectiveness (Phase 2)Study completedNCT01527500
What this trial is testing

Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge-related Macular Degeneration
Novartis Pharmaceuticals 158
Next Page